# Acuta Capital

Investor in San Francisco, California

## About Acuta Capital

Acuta Capital Partners is a healthcare-focused investment firm that primarily backs publicly listed and late-stage biotechnology companies. The firm concentrates on structured and post-IPO equity financings within the life sciences sector.

Acuta's activity is heavily weighted toward post-IPO equity rounds, providing growth capital to clinical- and commercial-stage biotech companies.

Notable investments include Surrozen, Aadi Bioscience, Enliven Therapeutics, Ocular Therapeutix, Tourmaline Bio, Taysha Gene Therapies, BioAtla, and Ventyx Biosciences.

## People

- **Scott Smith**, Chief Operating Officer

## Key Facts

- **Location:** San Francisco, California
- **Investor Type:** Venture Capital

## Investment Industries

- Biotech
- Medical/Healthcare

## How to Contact

Direct messaging and this investor's website are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/acuta-capital
- More investors: [Biotech Investors in California](https://askforfunding.com/site/angel-investors/california/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
